News Clip4:03
Bloomberg

Coronavirus Vaccine Unlikely to Become Available This Year, Professor Says

Higher Ed
Mar.03 -- Caitlin Rivers, professor of epidemiology at Johns Hopkins Bloomberg School of Public Health, discusses how the U.S. is dealing with the coronavirus outbreak. She speaks with Paul Allen and Emily Chang on "Bloomberg Markets."
News Clip9:07
Bloomberg

AstraZeneca's September Target for 30M Vaccine Doses Is 'Achievable,' Says CEO

Higher Ed
May.21 -- AstraZeneca CEO Pascal Soriot discusses his company's progress toward a coronavirus vaccine. He speaks on "Bloomberg The Open."
News Clip11:12
Bloomberg

Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption

Higher Ed
Jul.21 -- Novartis AG Chief Executive Officer Vasant Narasimhan discusses second-quarter earnings, efforts to find a Covid-19 vaccine, and growth prospects. He speaks on "Bloomberg Markets: European Open" after the Swiss drugmaker...
News Clip10:49
Bloomberg

Herd Immunity for Covid-19 Is 'a Fantasy': Dr. Haseltine

Higher Ed
Jun.15 -- William Haseltine, who designed the strategy to develop the first treatment for HIV/AIDS and is now chair and president of consulting group ACCESS Health International, talks about the coronavirus outbreak. He speaks with Haidi...
News Clip2:09
The Recount

Top 5 Clips of September 22nd

Higher Ed
President Biden announces the U.S. will donate 500 million COVID vaccine doses to low and middle-income countries. A law professor teaches Ted Cruz a lesson. And ESPN makes history with its first all-female MLB broadcast.
News Clip4:45
Bloomberg

University of Nottingham's Welsh On Malaysia's Political Turmoil

Higher Ed
University of Nottingham Asia Research Institute Malaysia Honorary Research Associate Bridget Welsh discusses about Malaysia's political future, following the resignation of the country's prime minister. She was speaking with David...
News Clip2:13
Bloomberg

Pfizer Plans to Request FDA Nod for Covid Booster

Higher Ed
Jul.08 -- Pfizer Inc. plans to request U.S. emergency authorization for a third booster dose of its vaccine, Robert Langreth reports on "Bloomberg Daybreak: Australia."
News Clip0:36
Curated Video

India Approves 2 COVID-19 Vaccines

Higher Ed
India to use vaccines developed by U.K. drugmaker AstraZeneca, India-based Bharat Biotech.
News Clip5:18
AFP News Agency

CLEAN : India trains workforce for Covid-19 vaccine rollout

9th - Higher Ed
Young trainees learn how to vaccinate at a Covid-19 vaccination training program in India, ahead of vaccine approvals and rollouts in the country (Footage by AFPTV via Getty Images)
News Clip2:59
Curated Video

Why Aren’t COVID Vaccines Getting To More People?

Higher Ed
Only 5 million of 20-million target got doses of vaccination by end of December.
News Clip4:04
Bloomberg

Covid-19 Measures Need Better Commitment in U.S.: Johns Hopkins

Higher Ed
Dec.11 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses guidelines on masks, medical restrictions on Covid-19 vaccines, and concerns about vaccine distribution to poorer nations. He...
News Clip6:11
Bloomberg

Chile Vice Minister on Vaccinations, Digital Trade Deal

Higher Ed
Jul.21 -- Rodrigo Yañez, Chile's vice minister of international economic relations, discusses the country's Covid-19 vaccination program. He also talks about the Digital Economy Partnership Agreement with Singapore and New Zealand. He...
News Clip1:20
Bloomberg

Senate’s Infrastructure Push Faces a Covid Roadblock

Higher Ed
Aug.03 -- Plans to pass a $550 billion infrastructure bill through the Senate this week hit a potential obstacle as Republican South Carolina Senator Lindsey Graham announced he tested positive for Covid-19 and would quarantine for 10...
News Clip6:27
Bloomberg

Okta CEO: Gov't Can Help Set Up Standards for Vaccine Passport

Higher Ed
Jun.21 -- Okta CEO and co-founder Todd McKinnon discusses the debate surrounding vaccine passports and the future of remote work with Bloomberg's Emily Chang on "Bloomberg Technology."
News Clip5:34
Bloomberg

RockCreek's Beschloss Is 'Very Excited' About Equities

Higher Ed
Mar.16 -- RockCreek Founder & CEO Afsaneh Beschloss says she's very excited about equities in the U.S. and Europe. She appears on "Bloomberg Surveillance."
News Clip12:19
Bloomberg

Connecticut Gov. Lamont on Schools, Stimulus, Vaccinations

Higher Ed
Mar.11 -- Connecticut Governor Ned Lamont discusses the potential impact of the federal stimulus on the state and the efforts to distribute the Covid-19 vaccines. He speaks with Bloomberg's David Westin on "Balance of Power."
News Clip8:51
Bloomberg

Novavax to File Vaccine in U.K. and U.S. in Q2, CEO Says

Higher Ed
Mar.12 -- Novavax Inc. Chief Executive Officer Stan Erck says the company's Covid-19 vaccine has been effective against variants. He speaks with Bloomberg's Alix Steel on "Bloomberg Markets."
News Clip7:51
Bloomberg

Novartis CEO ‘Cautiously Optimistic’ on Covid Impact in Fourth Quarter

Higher Ed
Oct.27 -- Novartis Chief Executive Officer Vas Narasimhan discusses the business impact of Covid-19, the race for a vaccine, and the company’s development of a coronavirus antibody treatment. He speaks on "Bloomberg Markets: European Open."
News Clip1:49
Curated Video

Maryland, D.C. Hospitals To Require Workers Get COVID Vaccine

Higher Ed
More hospitals are moving to require their workers to get vaccinated for COVID-19.
News Clip5:46
Bloomberg

Royal Caribbean CEO Says Most Ships Will Sail by Year-End

Higher Ed
Jun.28 -- Royal Caribbean Chief Executive Officer Richard Fain said Monday that he expects most of the company’s ships to be sailing by year-end and that he was “amazingly happy” with bookings he’s seeing for the next two years. He's on...
News Clip12:37
Bloomberg

Takeda Pharma's Venkayya on Global Race for Covid Vaccines

Higher Ed
Nov.22 -- Rajeev Venkayya, president of the global vaccine business unit of Japan's Takeda Pharmaceutical Co., discusses the latest developments in the global race for Covid-19 vaccines. The company said last month it will import and...
News Clip6:28
Bloomberg

Petrovax President on Covid-19 Drug, CanSino Vaccine Trials

Higher Ed
Nov.25 -- Mikhail Tsyferov, president at Petrovax, discusses tests of an existing immune system drug on Covid-19 patients and trials for a Chinese coronavirus vaccine. He speaks on "Bloomberg Markets."
News Clip4:22
Bloomberg

Covid Variant From India Triggers WHO Concern

Higher Ed
May.10 -- A fast-spreading strain of Covid-19 first identified in India will be classified as a variant of concern by the World Health Organization. The global health group will publish a detailed report on the variant, called B.1.617,...
News Clip5:12
Bloomberg

Airfinity CEO on Cautious Reopening for U.K.

Higher Ed
May.17 -- Airfinity CEO Rasmus Bech Hansen speaks to Bloomberg's Alix Steel about the U.K. reopening and vaccination numbers in India on "Bloomberg Markets: European Close".